vs
Side-by-side financial comparison of NextPlat Corp (NXPL) and Stereotaxis, Inc. (STXS). Click either name above to swap in a different company.
NextPlat Corp is the larger business by last-quarter revenue ($12.8M vs $8.6M, roughly 1.5× Stereotaxis, Inc.). NextPlat Corp runs the higher net margin — -40.2% vs -64.0%, a 23.8% gap on every dollar of revenue. On growth, Stereotaxis, Inc. posted the faster year-over-year revenue change (36.3% vs -21.1%). Over the past eight quarters, Stereotaxis, Inc.'s revenue compounded faster (12.1% CAGR vs -14.4%).
Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures.
NXPL vs STXS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.8M | $8.6M |
| Net Profit | $-5.1M | $-5.5M |
| Gross Margin | 14.3% | 50.1% |
| Operating Margin | -28.9% | -65.4% |
| Net Margin | -40.2% | -64.0% |
| Revenue YoY | -21.1% | 36.3% |
| Net Profit YoY | -70.6% | 26.4% |
| EPS (diluted) | — | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.8M | $8.6M | ||
| Q3 25 | $13.8M | $7.5M | ||
| Q2 25 | $13.2M | $8.8M | ||
| Q1 25 | $14.5M | $7.5M | ||
| Q4 24 | $16.2M | $6.3M | ||
| Q3 24 | $15.4M | $9.2M | ||
| Q2 24 | $17.0M | $4.5M | ||
| Q1 24 | $17.5M | $6.9M |
| Q4 25 | $-5.1M | $-5.5M | ||
| Q3 25 | $-2.2M | $-6.5M | ||
| Q2 25 | $-1.8M | $-3.8M | ||
| Q1 25 | $-1.3M | $-5.8M | ||
| Q4 24 | $-3.0M | $-7.5M | ||
| Q3 24 | $-4.2M | $-6.2M | ||
| Q2 24 | $-5.3M | $-5.8M | ||
| Q1 24 | $-1.5M | $-4.5M |
| Q4 25 | 14.3% | 50.1% | ||
| Q3 25 | 19.9% | 54.9% | ||
| Q2 25 | 21.8% | 52.0% | ||
| Q1 25 | 23.8% | 54.4% | ||
| Q4 24 | 16.8% | 50.7% | ||
| Q3 24 | 23.2% | 44.6% | ||
| Q2 24 | 34.5% | 73.6% | ||
| Q1 24 | 27.8% | 57.6% |
| Q4 25 | -28.9% | -65.4% | ||
| Q3 25 | -14.5% | -87.8% | ||
| Q2 25 | -13.8% | -45.2% | ||
| Q1 25 | -10.2% | -79.3% | ||
| Q4 24 | -14.1% | -120.3% | ||
| Q3 24 | -52.1% | -69.0% | ||
| Q2 24 | -64.1% | -133.7% | ||
| Q1 24 | -10.5% | -69.0% |
| Q4 25 | -40.2% | -64.0% | ||
| Q3 25 | -15.9% | -86.6% | ||
| Q2 25 | -13.5% | -43.5% | ||
| Q1 25 | -9.2% | -77.9% | ||
| Q4 24 | -18.6% | -118.5% | ||
| Q3 24 | -27.4% | -67.3% | ||
| Q2 24 | -31.3% | -129.6% | ||
| Q1 24 | -8.5% | -65.5% |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | $-0.05 | $-0.07 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | $-0.22 | $-0.08 | ||
| Q2 24 | — | $-0.07 | ||
| Q1 24 | $-0.08 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.7M | $13.4M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $17.3M | $13.5M |
| Total Assets | $27.5M | $52.3M |
| Debt / EquityLower = less leverage | 0.07× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.7M | $13.4M | ||
| Q3 25 | $13.9M | $10.5M | ||
| Q2 25 | $16.6M | $7.0M | ||
| Q1 25 | $17.7M | $10.6M | ||
| Q4 24 | $20.0M | $12.2M | ||
| Q3 24 | $20.4M | $10.7M | ||
| Q2 24 | $24.9M | $14.7M | ||
| Q1 24 | $23.5M | $17.6M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $1.4M | — |
| Q4 25 | $17.3M | $13.5M | ||
| Q3 25 | $21.4M | $6.3M | ||
| Q2 25 | $23.5M | $1.5M | ||
| Q1 25 | $25.3M | $2.9M | ||
| Q4 24 | $27.3M | $6.1M | ||
| Q3 24 | $22.5M | $10.8M | ||
| Q2 24 | $26.5M | $11.4M | ||
| Q1 24 | $31.2M | $14.6M |
| Q4 25 | $27.5M | $52.3M | ||
| Q3 25 | $30.0M | $45.6M | ||
| Q2 25 | $31.0M | $41.2M | ||
| Q1 25 | $35.2M | $45.7M | ||
| Q4 24 | $37.1M | $46.7M | ||
| Q3 24 | $41.1M | $50.9M | ||
| Q2 24 | $51.5M | $36.0M | ||
| Q1 24 | $65.1M | $39.5M |
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-302.0K | $-4.0M |
| Free Cash FlowOCF − Capex | $-339.0K | — |
| FCF MarginFCF / Revenue | -2.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-302.0K | $-4.0M | ||
| Q3 25 | $-2.7M | $-4.2M | ||
| Q2 25 | $-1.0M | $-3.7M | ||
| Q1 25 | $-2.1M | $-1.8M | ||
| Q4 24 | $-476.0K | $1.3M | ||
| Q3 24 | $-4.6M | $-4.3M | ||
| Q2 24 | $2.3M | $-3.1M | ||
| Q1 24 | $-2.7M | $-2.3M |
| Q4 25 | $-339.0K | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-1.1M | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | $-508.0K | — | ||
| Q3 24 | $-4.7M | $-4.3M | ||
| Q2 24 | $2.2M | — | ||
| Q1 24 | $-2.7M | — |
| Q4 25 | -2.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -8.0% | — | ||
| Q1 25 | -14.3% | — | ||
| Q4 24 | -3.1% | — | ||
| Q3 24 | -30.6% | -47.2% | ||
| Q2 24 | 13.2% | — | ||
| Q1 24 | -15.7% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.6% | 0.1% | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.4% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NXPL
| Healthcare Operations | $9.0M | 70% |
| Ecommerce Revenue | $3.8M | 30% |
STXS
| Disposables Service And Accessories | $5.3M | 61% |
| Systems | $3.4M | 39% |
